In this article, the author discusses the need to build an economic value strategy that addresses the sometimes disparate perspectives of key stakeholders. To read the article, click the link below.
Patient burden associated with acute & chronic resistant infections
Inspiring stakeholders to take action on antimicrobial resistance (AMR) starts with communicating the current and future burden of...